Unknown PHASE4 INTERVENTIONAL NCT00111371

Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia

Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dyslexia)

Sponsor: University Hospital Muenster

Conditions Dyslexia

Interventions Levodopa

Updated 6 times since 2017 Last updated: Dec 4, 2014 Started: Jan 31, 2005 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00111371, this PHASE4 trial focuses on Dyslexia and remains ongoing. Sponsored by University Hospital Muenster, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Muenster

Data source: University Hospital Muenster

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Münster, Germany